Sovihep D Sofosbuvir And Daclatasvir

Sovihep D Sofosbuvir And Daclatasvir

6500 INR/Bottle

Product Details:

  • Dosage 1 TABLET DAILY
  • Medicine Type Treatment of Chronic hepatitis C virus (HCV) infection
  • Grade A
  • Molecular Formula Sofosbuvir (400mg) + Velpatasvir (100mg)
  • Click to View more
X

Sovihep D Sofosbuvir And Daclatasvir Price And Quantity

  • 1 Bottle
  • 6500 INR/Bottle

Sovihep D Sofosbuvir And Daclatasvir Product Specifications

  • 1 TABLET DAILY
  • Treatment of Chronic hepatitis C virus (HCV) infection
  • A
  • Sofosbuvir (400mg) + Velpatasvir (100mg)

Sovihep D Sofosbuvir And Daclatasvir Trade Information

  • Cash on Delivery (COD) Cash Advance (CA)
  • 500 Bottle Per Day
  • 2 Days
  • Contact us for information regarding our sample policy
  • 1*28
  • Asia
  • All India

Product Description

Velasof Tablet is a combination of two antiviral medicines. This prescription medicine is used in the treatment of chronic hepatitis C virus (HCV) infection. It fights against the viruses to resolve the infection.

Velasof Tablet should be taken in the prescribed dose and duration. It can be taken with or without food, but take it at the same time daily. It is advised not to consume more than the recommended dose. It is important to inform your doctor if you have any health conditions such as liver or kidney disease. It is harmful to consume alcohol along with this medicine, so it is advised to limit or avoid alcohol. The course of the medicine should be completed for better results.

The common side effects of this medicine are tiredness and headache. You should drink plenty of fluid and eat a healthy diet to prevent or overcome the side effects. Before taking the medicine, inform your doctor if you are taking any other medicines or supplements.
Enter Buying Requirement Details
Email Id
Mobile number

Other Products in 'Sofosbuvir Tablets' category



Back to top
trade india member
PHARMA BROTHERS All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.